Viewing Study NCT07474103


Ignite Creation Date: 2026-03-26 @ 3:16 PM
Ignite Modification Date: 2026-03-31 @ 12:17 AM
Study NCT ID: NCT07474103
Status: RECRUITING
Last Update Posted: 2026-03-16
First Post: 2026-03-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: SCRT-NALIRIXELOX+Sintilimab as TNT for High-Risk LARC
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module